Cerrato NA, López RLJ, Ortíz IC

Language: Spanish
References: 21
Page: 305-310
PDF size: 155.61 Kb.

ABSTRACT

Objectives: To determine the usefulness of ACR categories in breast biopsy order’s in the Hospital ABC.
Materials and methods: Patients who appeared for the breast marking independently from BIRADS category, granted by the Hospital ABC Radiologist in charge.
Results: There were 33 patients (38 biopsies) without malignancy diagnosis for the category II. There were 67 patients (73 biopsies) and two positive malignancy diagnoses in category III. There were 68 patients (75 biopsies) and 18 positive malignancy diagnoses on category IV. There were 16 patients and 16 biopsies with 13 malignancy diagnosis patients on category V.
Conclusions: Breast Excisional biopsies shouldn’t de practiced to patients with lesions type II. Biopsy should be practiced based on the clinical and image context, on category III. It is necessary that the multidisciplinary Group involved in dealing the mammary pathology to be familiarized with the vocabulary of mastography findings classification and risks of malignancy for each group.

REFERENCES

1. Miller A, To T, Baines C, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years follow up. Ann Intern Med 2002; 137: 305-12.

2. Kopans Daniel. La mama en imagen. Segunda edición. Lippincott-Raven.

3. Jackman R, Nowels K, Rodriguez J, Marzoni F, Shepard M. Stereotactic, automated, large-core needle biopsy of nonpapable breast lesions: false negative and histologic underestimation rates after long-term follow-up. Radiology 1999; 210: 799-805.

4. Sickles E. Management of probably benign breast lesions. Radiol Clin N Am 1995; 33: 1123-9.

5. Kolb T, Lichy J, Newhouse J. Occult cancer in women with dense breasts: detection with screening US. Radiology 1998; 207: 191-9.

6. Majid A, Shaw E, Doherty R, Sharma N, Salvador X. Missed breast carcinoma: pitfalls and pearls. Radiographics 2003; 23: 881-95.

7. Liberman L, et al. The BI-RADS: positive predictive value of mammographic features and final asessment categories. AJR 1998; 171(1): 35-40.

8. Leung J. New modalities in breast imaging: digital mammography, positron emission tomography, and sestamibi scintimammography. Radiol Clin N Am 2002; 40: 467-82.

9. American College of Radiology: Breast Imaging Reporting and Data System (BIRADS). 3rd Ed. Reston: Va ACR; 1998.

10. Liberman L, Menell J. Breast imaging reporting and data system (BI-RADS). Radiol Clin N Am 2002; 40: 620-30.

11. Humphrey L, Helfand M, Chan B, Woolf S. Breast cancer screening: a summary of the evidence for the us preventive services task force. Ann intern Med 2002; 137: 347-60.

12. American Medical Association Council on Scientific Affairs: Mammographic screening for asymtomatic women. CSA Report 1999; 16: 15.

13. Basset Lawrence. Imaging of breast masses. Radiol Clin N Am 2000; 38: 669-91.

14. Caplan LS, Blackman, et al. Coding Mammograms using the Classification “probably benign finding-short interval followup suggested”. AJR 1999; 172(2): 339-42.

15. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 1993; 85:1644-56. X. Heilbrunn Ken S. The American College of Radiology’s Mammography Lexicon: Barking up the wrong tree? AJR 1994; 162: 593-4.

16. Jackman RJ, Marzoni FA. Needle-localized breast biopsy: why do we fail? Radiology 1997; 204: 677-84.

17. Kerlikowske K, Grady D, Barclay J, Frankel SD, Ominsky SH, Sickles EA. Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst 1998; 90: 1801-9.

18. Lee Carol. Screening mammography: proven benefit, continued controversy. Radiol Clin N Am 2002; 40: 395-407.

19. Liberman L. Clinical management issues in percutaneous core breast biopsy. Radiol Clin N Am 2000; 791-805.

20. Sickles Edward. Successful methods to reduce false-positive mammography interpretations. Radiol Clin N Am 2000; 38: 693-9.

21. Preventive services task force. Ann intern Med 2002; 137: 347-60.